Terms: = Endocrine gland cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
620 results:
1. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
2. Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression.
Bhattacharyya S; Oon C; Diaz L; Sandborg H; Stempinski ES; Saoi M; Morgan TK; López CS; Cross JR; Sherman MH
Nat Cancer; 2024 Feb; 5(2):283-298. PubMed ID: 38195933
[TBL] [Abstract] [Full Text] [Related]
3. SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation.
Gong TT; Liu FH; Xiao Q; Li YZ; Wei YF; Xu HL; Cao F; Sun ML; Jiang FL; Tao T; Ma QP; Qin X; Song Y; Gao S; Wu L; Zhao YH; Huang DH; Wu QJ
Commun Biol; 2024 Jan; 7(1):67. PubMed ID: 38195842
[TBL] [Abstract] [Full Text] [Related]
4. Challenge in optimizing robotic pancreaticoduodenectomy including nerve plexus hanging maneuver: a Japanese single center experience of 76 cases.
Mizumoto T; Takahara T; Nishimura A; Mii S; Uchida Y; Iwama H; Kojima M; Kato Y; Uyama I; Suda K
Surg Endosc; 2024 Feb; 38(2):1077-1087. PubMed ID: 38168732
[TBL] [Abstract] [Full Text] [Related]
5. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification.
Zhang J; Qi C; Li H; Ding C; Wang L; Wu H; Dai W; Wang C
Medicine (Baltimore); 2023 Dec; 102(51):e36656. PubMed ID: 38134066
[TBL] [Abstract] [Full Text] [Related]
6. Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic cancer - An Overview.
Tarasiuk A; Mirocha G; Fichna J
Curr Treat Options Oncol; 2023 Dec; 24(12):1852-1869. PubMed ID: 38079061
[TBL] [Abstract] [Full Text] [Related]
7. TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma.
Zhou Y; Jin J; Ji Y; Zhang J; Fu N; Chen M; Wang J; Qin K; Jiang Y; Cheng D; Deng X; Shen B
J Transl Med; 2023 Dec; 21(1):872. PubMed ID: 38037073
[TBL] [Abstract] [Full Text] [Related]
8. Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer.
Zhang Z; Zhou J; Guo R; Zhou Q; Wang L; Xiang X; Ge S; Cui Z
Medicine (Baltimore); 2023 Nov; 102(45):e34871. PubMed ID: 37960775
[TBL] [Abstract] [Full Text] [Related]
9. Oxfendazole Induces Apoptosis in Ovarian cancer Cells by Activating JNK/MAPK Pathway and Inducing Reactive Oxygen Species Generation.
Chen Y; Wen C; Zhong S; Huang L; Xiang Y; Ou Y; Li L; Tang W; Zhou C; Wu Z; Ye W; Wu S; Huang S; Li Z
Biol Pharm Bull; 2023; 46(11):1569-1575. PubMed ID: 37914359
[TBL] [Abstract] [Full Text] [Related]
10. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract] [Full Text] [Related]
11. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
12. Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk.
Qin H; Chen J; Bouchekioua-Bouzaghou K; Meng YM; Griera JB; Jiang X; Kong X; Wang M; Xu Q; Wong PP
J Transl Med; 2023 Oct; 21(1):702. PubMed ID: 37814317
[TBL] [Abstract] [Full Text] [Related]
13. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
14. Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas.
Machino H; Dozen A; Konaka M; Komatsu M; Nakamura K; Ikawa N; Shozu K; Asada K; Kaneko S; Yoshida H; Kato T; Nakayama K; Saloura V; Kyo S; Hamamoto R
Exp Mol Med; 2023 Oct; 55(10):2205-2219. PubMed ID: 37779141
[TBL] [Abstract] [Full Text] [Related]
15. Combination
Gunda V; Ghosh C; Hu J; Zhang L; Zhang YQ; Shen M; Kebebew E
Thyroid; 2023 Oct; 33(10):1201-1214. PubMed ID: 37675898
[No Abstract] [Full Text] [Related]
16. Protein Advanced Glycation End Products and Their Implications in Pancreatic cancer.
Senavirathna L; Pan S; Chen R
Cancer Prev Res (Phila); 2023 Nov; 16(11):601-610. PubMed ID: 37578815
[TBL] [Abstract] [Full Text] [Related]
17. Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial.
Xiong J; Wang M; Gao J; Zhou Y; Pang Y; Sun Y
PLoS One; 2023; 18(7):e0288863. PubMed ID: 37506116
[TBL] [Abstract] [Full Text] [Related]
18. TMPOP2 Inhibition Suppresses Pancreatic cancer Cell Migration and Development by Repressing The JNK/STAT3 Pathway.
Liang J; Cao H; Wang G; Wei L; Dong L; Chen G; Li Q; Zhu D
Adv Biol (Weinh); 2023 Dec; 7(12):e2300113. PubMed ID: 37469237
[TBL] [Abstract] [Full Text] [Related]
19. EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-jun signaling to promote the invasion of ovarian cancer cells.
Shen X; Jin X; Fang S; Chen J
Cell Mol Biol Lett; 2023 Jul; 28(1):53. PubMed ID: 37420173
[TBL] [Abstract] [Full Text] [Related]
20. Similarity of oncogenic protein expression in KRAS
Tanaka Y; Kamimura K; Shibata O; Ogawa K; Oda C; Abe H; Ikarashi S; Hayashi K; Yokoo T; Wakai T; Terai S
Biochem Biophys Res Commun; 2023 Sep; 673():29-35. PubMed ID: 37356142
[TBL] [Abstract] [Full Text] [Related]
[Next]